Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
BJU International|February 21, 2014
Development and external validation of a prognostic tool for prediction of cancer-specific mortality after complete loco-regional pathological staging for squamous cell carcinoma of the penisMaxine Sun, Rosa S Djajadiningrat, Hussain M Alnajjar, et al.
European Urology|August 31, 2010
Prognostic factors for occult inguinal lymph node involvement in penile carcinoma and assessment of the high-risk EAU subgroup: a two-institution analysis of 342 clinically node-negative patientsNiels M Graafland, Wayne Lam, Joost A P Leijte, et al.
European Urology|July 17, 2010
Nodal staging in penile carcinoma by dynamic sentinel node biopsy after previous therapeutic primary tumour resectionNiels M Graafland, Renato A Valdés Olmos, Willem Meinhardt, et al.
European Urology Focus|March 9, 2021
F-18 Fluorodeoxyglucose Positron Emission Tomography with Computed Tomography Has High Diagnostic Value for Pelvic and Distant Staging in Patients with High-risk Penile CarcinomaSarah R Ottenhof, Rosa S Djajadiningrat, Michelle W J Versleijen, et al.
European Urology Focus|February 14, 2018
Surgical and Oncological Outcomes in Patients After Vascularised Flap Reconstruction for Locoregionally Advanced Penile CancerSarah R Ottenhof, Andrew Leone, Rosa S Djajadiningrat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 6, 2009
Two-center evaluation of dynamic sentinel node biopsy for squamous cell carcinoma of the penisJoost A P Leijte, Ben Hughes, Niels M Graafland, et al.
Clinical Genitourinary Cancer|February 24, 2024
The Impact of a Multidisciplinary Tumor Board (MTB) on Treatment Decision Making for Patients With Renal Cell Carcinoma (RCC): 5-Year Data AnalysisLuna van den Brink, Annebeth E C Ruiter, Brunolf W Lagerveld, et al.
The Journal of Urology|August 7, 2013
Contemporary management of regional nodes in penile cancer-improvement of survival?Rosa S Djajadiningrat, Niels M Graafland, Erik van Werkhoven, et al.
European Urology Open Science|September 11, 2023
Indications and Outcomes for Deferred Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Combination Therapy: Can Systemic Therapy be Withdrawn in Patients with No Evidence of Disease?Elisabeth E Fransen van de Putte, Luna van den Brink, Mohamed A Mansour, et al.
European Urology Open Science|June 17, 2026
Corrigendum to "Long-term real-world survival outcomes with dual immune checkpoint blockade in synchronous metastatic renal cell carcinoma: implications for the design of prospective cytoreductive nephrectomy trials" [Eur. Urol. Open Sci. 83 (2026) 133-141]Leo Bickley, Elisabeth E Fransen van de Putte, Luna van den Brink, et al.
Pageof 3